Clinical trials recruiting for Frontotemporal Dementia (FTD)

Phase breakdown

Self-screener

Recruiting trials

• Comprehensive Assessment of Neurodegeneration and Dementia
  NCT03402919 · Phase: Not specified · Ages: 50 Years to 90 Years · Sex: All (male and female) · 19 locations
• Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
  NCT06856850 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• [18F]ACI-19626 PET in TDP-43 Proteinopathies
  NCT06891716 · Phase: Early Phase 1 · Ages: 40 Years to 70 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Frontotemporal Dementia (FTD) often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Frontotemporal Dementia (FTD) trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.